AU1157695A - Hybrid growth factors - Google Patents
Hybrid growth factorsInfo
- Publication number
- AU1157695A AU1157695A AU11576/95A AU1157695A AU1157695A AU 1157695 A AU1157695 A AU 1157695A AU 11576/95 A AU11576/95 A AU 11576/95A AU 1157695 A AU1157695 A AU 1157695A AU 1157695 A AU1157695 A AU 1157695A
- Authority
- AU
- Australia
- Prior art keywords
- growth factors
- hybrid growth
- hybrid
- factors
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5403—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58995890A | 1990-09-28 | 1990-09-28 | |
US589958 | 1990-09-28 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU87359/91A Division AU8735991A (en) | 1990-09-28 | 1991-09-26 | Hybrid growth factors |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1157695A true AU1157695A (en) | 1995-04-13 |
Family
ID=24360286
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU87359/91A Abandoned AU8735991A (en) | 1990-09-28 | 1991-09-26 | Hybrid growth factors |
AU11576/95A Abandoned AU1157695A (en) | 1990-09-28 | 1995-02-06 | Hybrid growth factors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU87359/91A Abandoned AU8735991A (en) | 1990-09-28 | 1991-09-26 | Hybrid growth factors |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0503050A4 (en) |
JP (1) | JPH05502463A (en) |
AU (2) | AU8735991A (en) |
CA (1) | CA2069746A1 (en) |
IE (1) | IE913426A1 (en) |
PT (1) | PT99107A (en) |
WO (1) | WO1992006116A1 (en) |
ZA (1) | ZA917766B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5718893A (en) * | 1984-04-15 | 1998-02-17 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
WO1992004455A1 (en) * | 1990-08-29 | 1992-03-19 | Genetics Institute, Inc. | Multidomain hematopoiesis stimulators |
DE69333243T2 (en) * | 1992-11-24 | 2004-08-19 | G.D. Searle & Co., Chicago | MUTTED INTERLEUKIN-3 (IL-3) POLYPEPTIDES |
US5738849A (en) * | 1992-11-24 | 1998-04-14 | G. D. Searle & Co. | Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them |
US6057133A (en) * | 1992-11-24 | 2000-05-02 | G. D. Searle | Multivariant human IL-3 fusion proteins and their recombinant production |
US6153183A (en) | 1992-11-24 | 2000-11-28 | G. D. Searle & Company | Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production |
US5501962A (en) * | 1993-06-21 | 1996-03-26 | G. D. Searle & Co. | Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same |
WO1995028427A1 (en) * | 1994-04-15 | 1995-10-26 | Imclone Systems Incorporated | Chimeric interleukin-3/mutein interleukin-6 lymphokine |
US5536495A (en) * | 1994-04-15 | 1996-07-16 | Foster; Preston F. | Use of G-CSF to reduce acute rejection |
ITFI940106A1 (en) * | 1994-05-27 | 1995-11-27 | Menarini Ricerche Sud Spa | HYBRID MOLECULE OF GM-CSF-L-EPO OR EPO-L-GM-CSF FORMULA FOR ERYTHROPOIETIC STIMULATION |
IT1271688B (en) * | 1994-08-04 | 1997-06-04 | Menarini Ricerche Sud Spa | HYBRID MOLECULES FOR ANTI-CANCER TREATMENT THEIR PREPARATION AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS |
EP0783003B1 (en) * | 1995-04-26 | 2006-11-22 | Kyowa Hakko Kogyo Co., Ltd. | G-CSF TPO fusion proteins |
US6066318A (en) * | 1995-10-05 | 2000-05-23 | G.D. Searle & Co. | Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors |
PT935752E (en) * | 1996-09-20 | 2002-03-28 | Ortho Mcneil Pharm Inc | METHODS FOR THE DETERMINATION OF ERITROPOIETIN IN VITRO BIOACTIVITY |
AU725547B2 (en) * | 1996-10-25 | 2000-10-12 | G.D. Searle & Co. | Multi-functional chimeric hematopoietic receptor agonists |
AU721196B2 (en) * | 1996-10-25 | 2000-06-29 | G.D. Searle & Co. | Circularly permuted erythropoietin receptor agonists |
US6967092B1 (en) | 1996-10-25 | 2005-11-22 | Mc Kearn John P | Multi-functional chimeric hematopoietic receptor agonists |
US6187564B1 (en) * | 1997-07-10 | 2001-02-13 | Beth Israel Deaconess Medical Center | DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics |
US6165476A (en) * | 1997-07-10 | 2000-12-26 | Beth Israel Deaconess Medical Center | Fusion proteins with an immunoglobulin hinge region linker |
ES2208798T3 (en) * | 1997-09-01 | 2004-06-16 | Aventis Pharma Deutschland Gmbh | RECOMBINANT HUMAN ERYTHROPOYETIN WITH AN ADVANTAGE GLICOSILATION PROFILE. |
WO1999041382A2 (en) * | 1998-02-17 | 1999-08-19 | Hyseq, Inc. | A novel interleukin-3 and uses thereof |
BR9917606A (en) * | 1998-11-06 | 2002-12-31 | Bio Sidus S A | Procedure for the purification of recombinant human erythropoietin from cell culture supernatants and recombinant human erythropoietin obtained with such procedure |
BRPI0110914B8 (en) | 2000-05-15 | 2021-05-25 | Hoffmann La Roche | 'liquid pharmaceutical composition, process for its preparation and use of a pharmaceutical composition' |
US7220407B2 (en) | 2003-10-27 | 2007-05-22 | Amgen Inc. | G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction |
CA2586365A1 (en) | 2004-11-05 | 2006-05-26 | Northwestern University | Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders |
CN102906108B (en) | 2010-03-04 | 2016-01-20 | 菲尼克斯公司 | For preparing the method for solubility recombinant interferon albumen without sex change |
PL2552949T3 (en) | 2010-04-01 | 2017-01-31 | Pfenex Inc. | Methods for g-csf production in a pseudomonas host cell |
EP2881414B1 (en) | 2012-07-31 | 2018-07-11 | Asahi Kasei Kabushiki Kaisha | Epoxy resin composition and cured article |
LT6161B (en) | 2013-09-27 | 2015-06-25 | Uab Profarma | Fused proteins of granulocyte colony-stimulating factor with other partners of growh factor, preferably with stem cell factor, and method of preparation thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2534222B2 (en) * | 1982-05-12 | 1996-09-11 | プレジデント アンド フエロウズ オブ ハ−バ−ド カレツジ | Fusion gene for mixed protein production |
US4935352A (en) * | 1985-10-21 | 1990-06-19 | Takeda Chemical Industries, Ltd. | Expression vector for animal cell line and use thereof |
US4935233A (en) * | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
EP0275300B1 (en) * | 1986-08-01 | 1996-01-03 | Commonwealth Scientific And Industrial Research Organisation | Recombinant vaccine |
WO1990001039A1 (en) * | 1988-07-20 | 1990-02-08 | Immunex Corporation | Nonglycosylated human interleukin-3 compositions |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
WO1991001004A1 (en) * | 1989-07-06 | 1991-01-24 | Seragen, Inc. | Hybrid molecules |
DE69007975T2 (en) * | 1989-08-22 | 1994-07-21 | Immunex Corp | FUSION PROTEIN CONSISTING OF GM-CSF AND IL-3. |
US5073627A (en) * | 1989-08-22 | 1991-12-17 | Immunex Corporation | Fusion proteins comprising GM-CSF and IL-3 |
IL96477A0 (en) * | 1989-12-01 | 1991-08-16 | Amgen Inc | Megakaryocyte production |
WO1992004455A1 (en) * | 1990-08-29 | 1992-03-19 | Genetics Institute, Inc. | Multidomain hematopoiesis stimulators |
-
1991
- 1991-09-26 WO PCT/US1991/007053 patent/WO1992006116A1/en not_active Application Discontinuation
- 1991-09-26 JP JP3517013A patent/JPH05502463A/en active Pending
- 1991-09-26 CA CA002069746A patent/CA2069746A1/en not_active Abandoned
- 1991-09-26 AU AU87359/91A patent/AU8735991A/en not_active Abandoned
- 1991-09-26 EP EP19910918221 patent/EP0503050A4/en not_active Withdrawn
- 1991-09-27 IE IE342691A patent/IE913426A1/en not_active Application Discontinuation
- 1991-09-27 PT PT99107A patent/PT99107A/en not_active Application Discontinuation
- 1991-09-27 ZA ZA917766A patent/ZA917766B/en unknown
-
1995
- 1995-02-06 AU AU11576/95A patent/AU1157695A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH05502463A (en) | 1993-04-28 |
WO1992006116A1 (en) | 1992-04-16 |
EP0503050A1 (en) | 1992-09-16 |
PT99107A (en) | 1992-08-31 |
ZA917766B (en) | 1993-03-29 |
CA2069746A1 (en) | 1992-03-29 |
IE913426A1 (en) | 1992-04-08 |
EP0503050A4 (en) | 1994-07-06 |
AU8735991A (en) | 1992-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1157695A (en) | Hybrid growth factors | |
AU7937791A (en) | Culture bag | |
AU639126B2 (en) | Oxorapamycin | |
AU614482B3 (en) | Receptacle | |
AU8791591A (en) | Tnf-muteins | |
AU7846991A (en) | Aminobenzodiazepines | |
AU2738392A (en) | Novel hybrid transforming growth factors | |
AU9030991A (en) | Improved capacitor-sensor | |
AU7956191A (en) | Transportsystem | |
AU7804691A (en) | N-pyridinesulfonyl-N-pyrimidinyl-or-triazinylureas | |
AU8764191A (en) | Ibuprofen-antihistamine combinations | |
AU3921993A (en) | Novel antler-derived bone growth factors | |
AU7726391A (en) | Slitterscorer | |
AU617287B3 (en) | Receptacle | |
AU640295B2 (en) | Containers | |
AU8143891A (en) | Boxes | |
AU8740291A (en) | 3d-spectacles | |
AU7566691A (en) | Compostor | |
AU7587991A (en) | Electrodermatome | |
AU8443991A (en) | Clear topped composter | |
AU8984191A (en) | Thiadiazinones | |
AU7922191A (en) | 2-acylamino-7-chlorobenzothiazoles | |
AU8710691A (en) | Ibuprofen-diuretic combinations | |
AU7296291A (en) | Carrier | |
AU7412191A (en) | Produce storage |